Answers are grounded in this paper and cite their sources.
The pattern of metastatic spread observed in this study further defines BRAF mutant CRC as a discrete disease subset. The authors demonstrated that, unlikely early stage disease, MSI is associated with poorer survival in metastatic CRC, although this is driven by its association with BRAF mutation.
No takes yet. Share an insight, caveat, or question.
Tran et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: